1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Vaccine Contract Manufacturing Market Report 2016-2026 : Leading Countries, Technologies and Companies

Vaccine Contract Manufacturing Market Report 2016-2026 : Leading Countries, Technologies and Companies

  • December 2015
  • 148 pages
  • ID: 3603814
  • Format: PDF
  • By Visiongain

Summary

Table of Contents

What can be expected from the vaccine contract manufacturing market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there.

Our 148-page report provides 76 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analysis and commercial developments.

See revenue forecasts for the leading international markets

How will leading national markets perform to 2026? Our study forecasts revenues in national markets including products, including:

- US
- Germany
- France
- Italy
- Spain
- UK
- Japan
- China
- Brazil
- Russia
- India

Leading companies and potential for market growth

Overall revenue for the vaccine contract manufacturing market will reach $1047.3m in 2019, our work forecasts. We predict good revenue growth through to 2026. Increasing demands for therapeutic vaccines and an ageing population will help drive the market for vaccines over the forecast period, which in turn helps drive the vaccine contract manufacturing business.

Our work analyses the key companies in the market. See visiongain’s analysis of leading companies, including these:

- Baxter BioPharma Solutions
- Boehringer Ingelheim
- Catalent
- Charles River Laboratories
- IDT Biologika
- Lonza
- Meridian Life Science
- Sigma Aldrich Fine Chemical (Merck)
- Synco Bio Partners

A company profile gives you the following information where available:

- Discussion of a company’s activities and outlook
- Company news relevant to the market

Discover capabilities, progress, and commercial prospects, helping you stay ahead.



What issues will affect Vaccine contract manufacturing industry?
Our new report discusses issues and events affecting the vaccine contract manufacturing market. You will find discussions, including qualitative analyses:
- The emergence of developing markets as manufacturing centres
- Increasing potential in both established and emerging markets

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Vaccine Contract Manufacturing Market 2016-2026 report helps you
In summary, our 148-page report gives you the following knowledge:
- Revenue forecasts to 2026 for the vaccine contract manufacturing market – discover the industry’s prospects, finding promising places for investments and revenues
- Revenue forecasts to 2026 for the leading national markets – US, Japan, EU5 (Germany, UK, France, Italy and Spain), China, India, Brazil and Russia
- Assessment of leading companies – analysis of vaccine manufacturing capabilities, revenue and news (Baxter BioPharma Solutions, Boehringer Ingelheim, Catalent, Charles River Laboratories, IDT Biologika, Lonza, Meridian Life Science, Sigma Aldrich Fine Chemical (Merck), Synco Bio Partners)
- Discussion of what stimulates and restrains companies and the market

Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Glycoprotein 41 (gp41) - Pipeline Review, H2 2019

Glycoprotein 41 (gp41) - Pipeline Review, H2 2019

  • $ 3500
  • December 2019

Glycoprotein 41 (gp41) - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Glycoprotein 41 (gp41) - Pipeline Review, H2 2019’; Glycoprotein 41 (gp41) pipeline Target constitutes ...

Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2019

Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019

Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2019SummaryHepatitis C Virus Envelope Protein E2 - E2 is a viral structural protein found in the hepatitis C virus. It is present on the viral ...

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2019

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2019

  • $ 3500
  • December 2019

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H2 2019SummaryHuman Papillomavirus Protein E7 (E7) pipeline Target constitutes close to 44 molecules. Out of which approximately 29 molecules are ...

Global Human Vaccines Industry $ 5600 February 2020


ref:plp2015

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on